• Citer

Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL †

par Rogiers, Anne ;Willemot, Laurence;McDonald, Laura;Van Campenhout, Hilde;Berchem, Guy ;Jacobs, Celine;Blockx, Nathalie;Rorive, Andrée;Neyns, Bart
Référence Cancers (Basel), 15, 19, 4823
Publication Publié, 2023-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL †
Auteur:	Rogiers, Anne; Willemot, Laurence; McDonald, Laura; Van Campenhout, Hilde; Berchem, Guy; Jacobs, Celine; Blockx, Nathalie; Rorive, Andrée; Neyns, Bart
Informations sur la publication:	Cancers (Basel), 15, 19, 4823
Statut de publication:	Publié, 2023-10
Sujet CREF:	Cancérologie
	Sciences bio-médicales et agricoles
Mots-clés:	adjuvant treatment
	effectiveness
	health-related quality of life
	melanoma
	nivolumab
	real-world
	safety
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2072-6694
	info:doi/10.3390/cancers15194823
	info:scp/85173828058